Clinical trial
Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in…
NCT00345787 · Mundipharma K.K., Industry · Completed
Key facts
| NCT number | NCT00345787 |
|---|---|
| Title | Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain |
| Official title | A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Osteoarthritic Pain of the Hip or Knee |
| Lead sponsor | Mundipharma K.K., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Osteoarthritis |
| Intervention type | Drug |
| Interventions | Placebo, Buprenorphine Transdermal System |
| Enrollment | 262 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 29, 2006 |
| Last update posted | Apr 15, 2008 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: